Alpha 2.0
Login Register
» Authors » Simonne Wright

Simonne Wright

Explore the profile of Simonne Wright including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 12
Followers 0
Related Specialties
Biomedical Engineering
Psychiatry
Psychology
Top 10 Co-Authors
Soraya Seedat
Virginia Chiocchia
Andrea Cipriani
Lea Milligan
Georgia Salanti
Spyridon Siafis
Carmen Moreno
Jennifer Potts
James Thomas
Toshi A Furukawa
Published In
Wellcome Open Res
BMJ Ment Health
Syst Rev
Affiliations
Soon will be listed here.
Recent Articles
1.
Predictors of study dropout in cognitive-behavioural therapy with a trauma focus for post-traumatic stress disorder in adults: An individual participant data meta-analysis
Wright S, Karyotaki E, Cuijpers P, Bisson J, Papola D, Witteveen A, et al.
BMJ Ment Health . 2024 Nov; 27(1). PMID: 39537555
Background: Available empirical evidence on participant-level factors associated with dropout from psychotherapies for post-traumatic stress disorder (PTSD) is both limited and inconclusive. More comprehensive understanding of the various factors that...
2.
Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
Siafis S, Chiocchia V, Macleod M, Austin C, Homiar A, Tinsdeall F, et al.
Wellcome Open Res . 2024 Jul; 9:182. PMID: 39036710
Background: Trace amine-associated receptor 1 (TAAR1) agonism shows promise for treating psychosis, prompting us to synthesise data from human and non-human studies. Methods: We co-produced a living systematic review of...
3.
Pro-dopaminergic pharmacological interventions for anhedonia in depression: protocol for a living systematic review of human and non-human studies
Ostinelli E, Chiocchia V, Macleod M, Browning M, Harmer C, Siafis S, et al.
Wellcome Open Res . 2024 Jul; 8:425. PMID: 39026608
Anhedonia is a key symptom of depression, and it has been suggested as a potential target for future individualised treatments. However, much is unknown about how interventions enhancing dopaminergic pathways...
4.
Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies
Siafis S, McCutcheon R, Chiocchia V, Ostinelli E, Wright S, Stansfield C, et al.
Wellcome Open Res . 2024 Apr; 8:365. PMID: 38634067
Background: There is an urgent need to develop more effective and safer antipsychotics beyond dopamine 2 receptor antagonists. An emerging and promising approach is TAAR1 agonism. Therefore, we will conduct...
5.
New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosis
Cipriani A, Seedat S, Milligan L, Salanti G, Macleod M, Hastings J, et al.
BMJ Ment Health . 2023 Jun; 26(1). PMID: 37290906
In anxiety, depression and psychosis, there has been frustratingly slow progress in developing novel therapies that make a substantial difference in practice, as well as in predicting which treatments will...
6.
Cortisol levels in different tissue samples in posttraumatic stress disorder patients versus controls: a systematic review and meta-analysis protocol
van den Heuvel L, Wright S, Suliman S, Stalder T, Kirschbaum C, Seedat S
Syst Rev . 2019 Jan; 8(1):7. PMID: 30616687
Background: Posttraumatic stress disorder (PTSD) is a disorder that develops following exposure to severely stressful events. Altered cortisol secretion has been reported in PTSD; however, results have been inconsistent. Previous...